Federal Trade Commission Report On Specialty Generic Drugs Will Curl Your Toenails

“A Growing Profit Center for Vertically Integrated Pharmacy Benefit Managers”

“The Big 3 PBMs’ affiliated pharmacies generated significant and growing levels of revenue in excess of estimated acquisition cost (NADAC) on the most highly marked up specialty generic drugs…………… the Big 3 PBMs also appeared to take in significant income from spread pricing………….plan sponsors in particular should be aware that they and their members are paying the Big 3 PBMs and their affiliated pharmacies very significant markups over the acquisition costs for critical medications.”

Continue reading Federal Trade Commission Report On Specialty Generic Drugs Will Curl Your Toenails